US BROKER MOVES: AMAT upgraded at Susquehanna; SNOW downgraded at Barclays

UPGRADES

Advanced Energy (AEIS) Upgraded to Positive at Susquehanna; PT USD 300
Airbnb (ABNB) Upgraded to Buy at B Riley; PT USD 170
Akamai (AKAM) Upgraded to Overweight at Morgan Stanley; PT USD 115
Albemarle (ALB) Upgraded to Sector Outperform at Scotiabank; PT USD 200
Amphenol (APH) Upgraded to Overweight at Barclays
Appian (APPN) Upgraded to Overweight at Morgan Stanley
Applied Materials (AMAT) Upgraded to Positive at Susquehanna; PT USD 400
Comcast (CMCSA) Upgraded to Buy at BofA; PT USD 37
Conoco (COP) Upgraded to Overweight at Wells Fargo; PT USD 132
Crinetics Pharma (CRNX) Upgraded to Buy at Goldman; PT USD 67
Datadog (DDOG) Upgraded to Overweight at Morgan Stanley; PT USD 180
Frontline PLC (FRO) Upgraded to Buy at Clarksons; PT USD 28.33
Liberty Formula One (FWONA) Upgraded to Outperform at Bernstein; PT USD 111
Oportun (OPRT) Upgraded to Neutral at JPMorgan; PT USD 5.50
Pebblebrook (PEB) Upgraded to Outperform at Baird; PT USD 15
Pool Corp (POOL) Upgraded to Outperform at Baird; PT USD 320
Rocket Cos. (RKT) Upgraded to Neutral at JPMorgan; PT USD 24
Trade Desk (TTD) Upgraded to Neutral at MoffettNathanson LLC; PT USD 39
Trex (TREX) Upgraded to Buy at DA Davidson; PT USD 50
Vertex Pharmaceuticals (VRTX) Upgraded to Outperform at Bernstein

DOWNGRADES

Allstate (ALL) Downgraded to Hold at TD Cowen; PT USD 231
American Electric Power (AEP) Downgraded to Neutral at BofA
American Woodmark (AMWD) Downgraded to Neutral at Baird; PT USD 60
Amkor Technology (AMKR) Downgraded to Neutral at UBS; PT USD 55
Arrow Financial (AROW) Downgraded to Market Perform at Hovde Group
Axalta (AXTA) Downgraded to Neutral at UBS; PT USD 35
Brunswick (BC) Downgraded to Hold at Texas Capital; PT USD 90
CrowdStrike (CRWD) Downgraded to Sector Weight at KeyBanc
Datadog (DDOG) Downgraded to Sell at Goldman
DoubleVerify (DV) Downgraded to Equal-Weight at Barclays; PT USD 12
Gitlab (GTLB) Downgraded to Equal-Weight at Morgan Stanley; PT USD 42
Gitlab (GTLB) Downgraded to Underweight at Barclays; PT USD 34
HomeTrust Banc (HTB) Downgraded to Market Perform at Hovde Group
Nutanix (NTNX) Downgraded to Equal-Weight at Morgan Stanley
OneMain (OMF) Downgraded to Underweight at JPMorgan; PT USD 65
Perimeter Solutions (PRM) Downgraded to Neutral at UBS; PT USD 31
Range Resources (RRC) Downgraded to Equal-Weight at Wells Fargo; PT USD 43
Seadrill (SDRL) Downgraded to Sell at Citi; PT USD 32
SLM (SLM) Downgraded to Underweight at JPMorgan; PT USD 25
Snowflake (SNOW) Downgraded to Equal-Weight at Barclays; PT USD 250
Sunstone Hotel (SHO) Downgraded to Neutral at Baird; PT USD 10
Triumph Financial Inc (TFIN) Downgraded to Neutral at B Riley; PT USD 70

INITIATIONS

Allot Ltd (ALLT) Initiated at New Overweight at Cantor; PT USD 15
Andersen Group (ANDG) Initiated at New Outperform at William Blair
Andersen Group (ANDG) Initiated at New Buy at Deutsche Bank; PT USD 30
Andersen Group (ANDG) Initiated at New Buy at Truist Secs; PT USD 32
Andersen Group (ANDG) Initiated at New Equal-Weight at Wells Fargo; PT USD 25
Andersen Group (ANDG) Initiated at New Outperform at Baird; PT USD 40
Andersen Group (ANDG) Initiated at New Buy at UBS; PT USD 28
Andersen Group (ANDG) Initiated at New Equal-Weight at Morgan Stanley; PT USD 22
CBIZ (CBZ) Initiated at New Hold at Deutsche Bank; PT USD 60
Claritev Corp (CTEV) Initiated at New Buy at Guggenheim; PT USD 43
Fulcrum Therapeutics (FULC) Initiated at New Overweight at JPMorgan; PT USD 20
Hims & Hers Health (HIMS) Initiated at New Inline at Evercore ISI; PT USD 33
Medline (MDLN) Initiated at New Outperform at Bernstein; PT USD 49
Medline (MDLN) Initiated at New Buy at BTIG; PT USD 50
Medline (MDLN) Initiated at New Buy at TD Cowen; PT USD 46
Medline (MDLN) Initiated at New Outperform at William Blair
Medline (MDLN) Initiated at New Outperform at Mizuho Securities; PT USD 48
Medline (MDLN) Initiated at New Equal-Weight at Wells Fargo; PT USD 42
Medline (MDLN) Initiated at New Overweight at Barclays; PT USD 50
Medline (MDLN) Initiated at New Buy at Truist Secs; PT USD 52
Medline (MDLN) Initiated at New Neutral at Rothschild & Co Redburn; PT USD 42
Medline (MDLN) Initiated at New Outperform at Baird; PT USD 48
Medline (MDLN) Initiated at New Overweight at JPMorgan; PT USD 50
Medline (MDLN) Initiated at New Buy at UBS; PT USD 48
Medline (MDLN) Initiated at New Buy at Stifel; PT USD 46
Medline (MDLN) Initiated at New Buy at Jefferies; PT USD 50
Medline (MDLN) Initiated at New Outperform at BMO; PT USD 45
Medline (MDLN) Initiated at New Buy at Goldman; PT USD 49
Medline (MDLN) Initiated at New Overweight at Piper Sandler; PT USD 50
Medline (MDLN) Initiated at New Outperform at RBC; PT USD 47
Medline (MDLN) Initiated at New Outperform at Leerink; PT USD 48
Medline (MDLN) Initiated at New Overweight at Morgan Stanley; PT USD 48
Netflix (NFLX) Initiated at New Buy at HSBC; PT USD 107
Neumora Therapeutics (NMRA) Initiated at New Outperform at Leerink; PT USD 8